The hypertension peril: lessons from CETP inhibitors

M Hermann, FT Ruschitzka - Current hypertension reports, 2009 - Springer
Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …

The hypertension peril: Lessons from CETP inhibitors

M Hermann, FT Ruschitzka - Current Hypertension Reports, 2009 - infona.pl
Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …

The hypertension peril: lessons from CETP inhibitors.

M Hermann, FT Ruschitzka - Current Hypertension Reports, 2009 - europepmc.org
Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …

The hypertension peril: Lessons from CETP inhibitors

M Hermann, FT Ruschitzka - Current Hypertension Reports, 2009 - search.proquest.com
Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …

[PDF][PDF] The Hypertension Peril: Lessons From CETP Inhibitors

M Hermann, FT Ruschitzka - Current Hypertension Reports, 2009 - academia.edu
Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …

The hypertension peril: lessons from CETP inhibitors.

M Hermann, FT Ruschitzka - Current hypertension reports, 2009 - sonar.ch
English Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable
of increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing …

The hypertension peril: lessons from CETP inhibitors

M Hermann, FT Ruschitzka - Current hypertension …, 2009 - pubmed.ncbi.nlm.nih.gov
Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …

The hypertension peril: lessons from CETP inhibitors

M Hermann, F Ruschitzka - Current Hypertension Reports, 2009 - zora.uzh.ch
Pharmacologic inhibitors of the cholesteryl ester transfer protein (CETP) are capable of
increasing HDL cholesterol by 50% to 100% in humans. Despite intriguing antiatherogenic …

[引用][C] The hypertension peril: Lessons from CETP inhibitors

M Hermann, FT Ruschitzka - Current hypertension reports, 2009 - Springer

[引用][C] The hypertension peril: Lessons from CETP inhibitors

M Hermann, FT Ruschitzka - Current Hypertension Reports, 2009 - Springer